What is MedPLus Pharmacy?
MedPlus Pharmacy operates as a critical healthcare infrastructure provider, specializing in complex clinical services such as infusion therapy and medication therapy management. With a legacy spanning over 25 years, the company has carved out a distinct market position by integrating 340B solutions with personalized patient care. Their service portfolio is specifically engineered to address the multifaceted health requirements of the senior population, offering essential support through co-pay assistance programs, immunization services, and logistical support like free delivery. By bridging the gap between clinical pharmacy expertise and community-based accessibility, MedPlus Pharmacy serves as a vital link in the regional healthcare ecosystem, ensuring that high-acuity patients receive consistent and affordable pharmaceutical support.
How much funding has MedPLus Pharmacy raised?
MedPLus Pharmacy has raised a total of $77K across 1 funding round:
Debt
$77K
Debt (2021): $77K with participation from PPP
Key Investors in MedPLus Pharmacy
PPP
Public-Private Partnership
What's next for MedPLus Pharmacy?
With the recent infusion of capital, MedPlus Pharmacy is poised to accelerate its operational footprint and enhance its technological capabilities in medication management. The strategic focus will likely shift toward optimizing 340B program efficiencies and expanding the reach of its infusion therapy services to a broader demographic. As the company transitions through this significant Series B/C stage, the management team is expected to prioritize infrastructure investments that support long-term scalability while maintaining the high-touch, personalized care model that has defined their reputation. Future growth will likely be driven by deepening partnerships with regional health systems and further diversifying their specialty pharmacy offerings to meet the evolving demands of the aging population in the Washington DC corridor.
See full MedPLus Pharmacy company page
